ATTRUBY

Serial Number 97288153
Registration 7819464
700

Registration Progress

Application Filed
Feb 28, 2022
Under Examination
Mar 14, 2023
Approved for Publication
Jan 17, 2023
Published for Opposition
Jan 17, 2023
Registered
Jun 3, 2025

Trademark Image

ATTRUBY

Basic Information

Serial Number
97288153
Registration Number
7819464
Filing Date
February 28, 2022
Registration Date
June 3, 2025
Published for Opposition
January 17, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 3, 2025
Registration
Registered
Classes
005

Rights Holder

BridgeBio Pharma, Inc.

03
Address
3160 Porter Dr., Suite 250
Palo Alto, CA 94304

Ownership History

BridgeBio Pharma, Inc.

Original Applicant
03
Palo Alto, CA

BridgeBio Pharma, Inc.

Owner at Publication
03
Palo Alto, CA

BridgeBio Pharma, Inc.

Original Registrant
03
Palo Alto, CA

Legal Representation

Attorney
Jessica L. Rothstein

USPTO Deadlines

Next Deadline
2036 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-06-03)
Due Date
June 03, 2031
Grace Period Ends
December 03, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

33 events
Date Code Type Description Documents
Jun 3, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 9, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 9, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 16, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 16, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 6, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 6, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 5, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 5, 2025 IUAF S USE AMENDMENT FILED Loading...
Feb 5, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 5, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 28, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 28, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 28, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 9, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 8, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 8, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 8, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 15, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 11, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 11, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 11, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 14, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 17, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 28, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 14, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 13, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 13, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 13, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 11, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 3, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 3, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders
First Use Anywhere: Nov 22, 2024
First Use in Commerce: Nov 22, 2024

Classification

International Classes
005